Atopy
23
2
5
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
91.7%
+5.2% vs benchmark
4%
1 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (23)
NIAID Centralized Sequencing Protocol
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
NiPPeR Randomised Trial - Child Follow Up Study
Omalizumab Before Onset of Exacerbations
Microbiome, Atopic Disease, Prematurity
Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
Xolair Interventional Study in ASD Patients With Comorbid Atopy
Biodiversity Intervention and Atopic Sensitization
Protection Against Allergy: Study in Rural Environment - Part IV
Inhibitory Receptors in Eosinophils of Atopic Subjects
The JOIN Project: The Air in Diagnosis and Prevention of Asthma and Allergy
Imaging Study of the Lungs During an Allergic Asthma Attack
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001
Intestinal Microbiota Composition After Antibiotic Treatment in Early Life
Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health
Vitamin A Supplementation at Birth and Atopy in Childhood
Predictors of Cord Blood Immunoglobin E (IgE) Levels